Industry
Azurity Pharmaceuticals
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
Phase 4
2(100.0%)
2Total
Phase 4(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT01733082Recruiting
The Mycophenolate Pregnancy Registry
Role: collaborator
NCT06534502Phase 4Not Yet Recruiting
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
Role: lead
NCT07328542Phase 4Not Yet Recruiting
Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Role: lead
All 3 trials loaded